Agonist-selective regulation of the mu opioid receptor by βarrestins

Agonist-selective regulation of the mu opioid receptor by βarrestins

Bibliographic Details
Main Author:	Groer, Chad E.
Language:	English
Published:	The Ohio State University / OhioLINK 2010
Subjects:	Pharmacology opioid arrestin herkinorin morphine
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1284396146

Similar Items

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
by: Justyna Piekielna-Ciesielska, et al.
Published: (2021-12-01)

Opioid-Induced Side Effects in Beta-arrestin2 adn G Protein-Coupled Receptor Kinase Knockout Mice
by: Raehal, Kirsten Michele
Published: (2009)

Differenzierte β-Arrestin2 Rekrutierung am μ-Opioid Rezeptor durch klinisch eingesetzte Opioide
by: Mayer, Stefanie
Published: (2021)

EFFECTS OF MU OPIOID RECEPTOR AGONISTS ON INTRACRANIAL SELF-STIMULATION IN THE ABSENCE AND PRESENCE OF “PAIN” IN RATS
by: Altarifi, Ahmad
Published: (2013)

Density-Dependent Mu Opioid Receptor Function Revealed by Single-Molecule Microscopy
by: Holsey, Michael David
Published: (2019)

ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression
by: Iris Bachmutsky, et al.
Published: (2021-05-01)

Improvement of Morphine-Mediated Analgesia by Inhibition of β-Arrestin 2 Expression in Mice Periaqueductal Gray Matter
by: Yuting Li, et al.
Published: (2009-03-01)

Synergistic Actions of Mu-Opioid and CB2 Receptor Agonists in Rodent Models of Acute and Chronic Pain
by: Grenald, Shaness A., et al.
Published: (2016)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
by: Muzeyyen Ugur, et al.
Published: (2018-11-01)

Receptores opioides até o contexto atual
by: Rodrigo Tomazini Martins, et al.

Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to “Biased Opioids”?
by: Robert Root-Bernstein, et al.
Published: (2018-01-01)

Differential regulation of serotonin 2A receptor responsiveness by agonist-directed interactions with beta-arrestin2
by: Schmid, Cullen L.
Published: (2011)

In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling
by: Xiao Zhang, et al.
Published: (2020-06-01)

Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions between GPCRs and β-arrestins
by: Martina eKocan, et al.
Published: (2011-01-01)

A Facile Synthesis for Novel Loperamide Analogs as Potential &#956; Opioid Receptor Agonists
by: Xiaofeng Bao, et al.
Published: (2012-12-01)

β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane
by: Barbora Melkes, et al.
Published: (2020-06-01)

Decoding Partner Specificity of Opioid Receptor Family
by: Carlos A. V. Barreto, et al.
Published: (2021-09-01)

Contribution of metabotropic glutamate receptors to opioid dependence
by: Fundytus, Marian Elaine.
Published: (1996)

The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor
by: Gábor Turu, et al.
Published: (2019-08-01)

G Protein-Coupled Receptor Kinases (GRKs) and Beta-Arrestins: New Insights into Disease Regulators
Published: (2020)

Pharmacological Chaperones Attenuate the Development of Opioid Tolerance
by: Youta Okuyama, et al.
Published: (2020-10-01)

Ligand biased signaling of opioid agonists forphosphorylation and regulation of μ -opioid receptors
by: Basti, Vida
Published: (2013)

Molecular Signaling Mechanisms at the µ-Opioid Receptor
by: Schmid, Benedikt
Published: (2020)

β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility
by: Jihee Kim, et al.
Published: (2018-12-01)

Сentral and peripheral mechanisms of mu-opioid analgesia and tolerance
by: Yu. A. Kolesnikov
Published: (2020-03-01)

Interaction of Protease-Activated Receptor 2 with G Proteins and Beta-Arrestin 1 Studied by Bioluminescence Resonance Energy Transfer
by: Mohammed Akli eAyoub, et al.
Published: (2013-12-01)

Nitric Oxide and S-Nitrosylation in Cardiac Regulation: G Protein-Coupled Receptor Kinase-2 and β-Arrestins as Targets
by: Gizem Kayki-Mutlu, et al.
Published: (2021-01-01)

The orphan receptor GPR88 blunts the signaling of opioid receptors and multiple striatal GPCRs
by: Thibaut Laboute, et al.
Published: (2020-01-01)

The Role of β-Arrestins in Regulating Stem Cell Phenotypes in Normal and Tumorigenic Cells
by: Georgios Kallifatidis, et al.
Published: (2020-12-01)

Uncovering the Functional Implications of Mu- and Delta-opioid Receptor Heteromerization in the Brain
by: Kabli, Noufissa
Published: (2013)

Uncovering the Functional Implications of Mu- and Delta-opioid Receptor Heteromerization in the Brain
by: Kabli, Noufissa
Published: (2013)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
by: Vsevolod V. Gurevich, et al.
Published: (2019-02-01)

Pharmacological assessment of adjuncts to enhance mu-opioid receptor agonist antinociception in male rhesus monkeys: Does one + one = three?
by: Cornelissen, Jeremy
Published: (2019)

Receptor-Arrestin Interactions: The GPCR Perspective
by: Mohammad Seyedabadi, et al.
Published: (2021-02-01)

Retention in the Austrian opioid agonist treatment system: a national prospective cohort study
by: Martin Busch, et al.
Published: (2021-02-01)

<it>In vivo </it>antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
by: Guillemyn Karel, et al.
Published: (2012-01-01)

Biased Opioid Ligands
by: Abdelfattah Faouzi, et al.
Published: (2020-09-01)

Fonctions de la protéine suppresseur de tumeurs PTEN : régulation par les β-arrestines et par l’interaction intramoléculaire
by: Lima Fernandes, Evelyne
Published: (2012)

Therapeutic Potential of Targeting ß-Arrestin
by: Richard A. Bond, et al.
Published: (2019-03-01)

Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
by: Xin-Yan Zhang, et al.
Published: (2020-06-01)